shutterstock_57369385

Drug Combinations and Emerging Interactions

June 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug combinations, drug resistance, feature

Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …

Humira set to face new European biosimilar rival

June 26, 2017
Sales and Marketing CHMP, EMA, Samsung Bioepis

A position opinion from the EMA for Samsung Bioepis’ biosimilar of Humira looks set to unleash a second rival to …

roche

Roche haemophilia therapy cuts bleed rate by 87%

June 26, 2017
Research and Development, Sales and Marketing Roche, haemophilia

Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate …

nhs_parliament_2_4

Public dissatisfaction with NHS found to be growing, says BMA

June 26, 2017
Medical Communications, Sales and Marketing BMA, NHS

The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …

novo_nordisk_flag

Promising Phase 2 obesity data for Novo’s diabetes drug

June 26, 2017
Research and Development, Sales and Marketing Novo Nordisk

Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced …

Astellas receives further year suspension from ABPI

June 26, 2017
Medical Communications, Sales and Marketing ABPI, Astellas

The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …

Woodley Equipment Attending Outsourcing in Clinical Trials UK & Ireland 2017

June 23, 2017

Woodley Equipment is attending Outsourcing in Clinical Trials UK and Ireland Conference taking place at the Royal Garden Hotel, London …

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017
Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …

novartis_outside_1

Novartis lung cancer combo receives FDA approval

June 23, 2017
Medical Communications, Sales and Marketing NSCLC, Novartis

Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …

needle-1291170_960_720

HIV cases in gay men fall for the first time in England

June 23, 2017
Medical Communications HIV, PrEP

For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …

shutterstock_187433765

Rare cancers through the looking glass

June 23, 2017
Medical Communications, Research and Development pharmafile, rare cancer

Rare cancers are not so rare after all. According to the organisation Rare Cancer Europe more than 4.3 million people …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …

shutterstock_311949818

Immune system attacks the brain in Alzheimer’s, study suggests

June 22, 2017
Research and Development Alzheimer's

New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease, seemingly confirming a …

ovarian_cancer

Risk estimate produced from long-term BRCA gene study

June 22, 2017
Research and Development BRCA, Cancer Research UK, University of Cambridge

A new study funded by Cancer Research UK and carried out by the University of Cambridge has identified the ages …

shutterstock_3

New research unlocks the key to slowing cancer metastasis

June 22, 2017
Research and Development Cancer, metastasis

Stemming from a theory she developed as a sophomore at John Hopkins University in Maryland, Hasini Jayatilaka and a team …

novartis_headquarters

Novartis pulls off surprise success in cardiovascular risk

June 22, 2017
Research and Development, Sales and Marketing Novartis

Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise …

FDA’s Gottlieb draws those ‘gaming’ system into pricing debate

June 22, 2017
Medical Communications, Sales and Marketing Drug pricing, FDA, Trump

President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …

fda2outsideweb

FDA locks down import from 3 Indian IPCA facilities

June 21, 2017
Manufacturing and Production, Research and Development FDA, India, Ipca

More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of …

shire_image

10 years later, Shire gains FDA approval for ADHD drug

June 21, 2017
Research and Development, Sales and Marketing ADHD, Shire

Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more …

Immune system exhaustion associated with irritable bowel syndrome

June 21, 2017
Research and Development IBS, irritable bowel syndrome, t cells

Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the …

The Gateway to Local Adoption Series

Latest content